Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)
| 0.60 BATS BZX Real-Time Price As of Mar 21 |  0.00 / 0.00%Today’s Change | 0.53 Today|||52-Week Range 3.36 | -10.04% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 150.0K | 0.00 | |
| Depreciation And Amortization | 8.0K | 7.0K | 7.0K | 6.0K | ||
| Operating Expenses | Gross Income | -8.0K | -7.0K | -- | -6.0K | |
| General Expenses | 2.5M | 2.4M | 2.6M | 2.2M | ||
| Research And Development | 1.2M | 1.2M | 1.1M | 1.0M | ||
| Total Operating Expenses | 2.5M | 2.5M | 2.6M | 2.2M | ||
| Non-Operating Expenses | Operating Income | -2.5M | -2.5M | -2.5M | -2.2M | |
| Other Expenses | 27.0K | 1.0K | 2.0K | 15.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -2.4M | -2.4M | -2.4M | -2.1M | |
| Income Taxes | -502.0K | -301.0K | -352.0K | -268.0K | ||
| Preferred Dividend | -50.0K | -50.0K | -50.0K | -50.0K | ||
| Net Income | -1.9M | -2.1M | -2.0M | -1.8M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 12.0M | 12.0M | 12.2M | 13.6M | |
| Shares To Calculate EPS Diluted | 12.0M | 12.0M | 12.2M | 13.6M | ||
| Earnings Per Share | EPS | -$0.16 | -$0.18 | -$0.17 | -$0.14 | |
| EPS Diluted | -$0.16 | -$0.18 | -$0.17 | -$0.14 | ||
